Ticker Symbol: TALS
Talaris Therapeutics Inc
$15.43 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001827506
Company Profile
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing an innovative method of allogeneic hematopoietic stem cell transplantation with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune and metabolic disorders. Talaris maintains corporate offices in Boston, Mass., and its cell processing facility in Louisville, Ky.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: talaristx.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.61
Change:
$0.02
(
0.77%)
Days Range: $2.60 - $2.71
Beta: 1.19
52wk. High: $3.29
52wk. Low: $0.89
Ytd. Change 154.69%
50 Day Moving Average: $2.86
200 Day Moving Average: $2.67
Shares Outstanding: 42764165
Valuation
Market Cap: 11.2B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A